1. Home
  2. NTCT vs LGND Comparison

NTCT vs LGND Comparison

Compare NTCT & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTCT
  • LGND
  • Stock Information
  • Founded
  • NTCT 1984
  • LGND 1987
  • Country
  • NTCT United States
  • LGND United States
  • Employees
  • NTCT N/A
  • LGND N/A
  • Industry
  • NTCT EDP Services
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTCT Technology
  • LGND Health Care
  • Exchange
  • NTCT Nasdaq
  • LGND Nasdaq
  • Market Cap
  • NTCT 1.7B
  • LGND 2.1B
  • IPO Year
  • NTCT 1999
  • LGND 1992
  • Fundamental
  • Price
  • NTCT $21.61
  • LGND $104.48
  • Analyst Decision
  • NTCT Hold
  • LGND Strong Buy
  • Analyst Count
  • NTCT 1
  • LGND 8
  • Target Price
  • NTCT $25.00
  • LGND $144.71
  • AVG Volume (30 Days)
  • NTCT 426.5K
  • LGND 102.0K
  • Earning Date
  • NTCT 05-08-2025
  • LGND 05-08-2025
  • Dividend Yield
  • NTCT N/A
  • LGND N/A
  • EPS Growth
  • NTCT N/A
  • LGND N/A
  • EPS
  • NTCT N/A
  • LGND N/A
  • Revenue
  • NTCT $822,679,000.00
  • LGND $181,488,000.00
  • Revenue This Year
  • NTCT $0.22
  • LGND $16.47
  • Revenue Next Year
  • NTCT $2.04
  • LGND $19.44
  • P/E Ratio
  • NTCT N/A
  • LGND N/A
  • Revenue Growth
  • NTCT N/A
  • LGND 53.40
  • 52 Week Low
  • NTCT $17.10
  • LGND $72.61
  • 52 Week High
  • NTCT $27.89
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • NTCT 61.28
  • LGND 46.11
  • Support Level
  • NTCT $19.98
  • LGND $99.24
  • Resistance Level
  • NTCT $22.34
  • LGND $107.37
  • Average True Range (ATR)
  • NTCT 0.64
  • LGND 4.05
  • MACD
  • NTCT 0.13
  • LGND -0.33
  • Stochastic Oscillator
  • NTCT 70.45
  • LGND 39.37

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: